vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and NEWMARKET CORP (NEU). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $669.7M, roughly 1.8× NEWMARKET CORP). NEWMARKET CORP runs the higher net margin — 17.6% vs 0.9%, a 16.7% gap on every dollar of revenue. On growth, NEWMARKET CORP posted the faster year-over-year revenue change (-4.5% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -2.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

NewMarket Corporation, is a publicly traded American company that primarily serves the petroleum additives industry. The company is based in Richmond, Virginia, and has operations in North America, Latin America, Europe, the Middle East and Asia Pacific. The company's predecessor, the Albemarle Paper Manufacturing Company, was founded in 1887.

ALHC vs NEU — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.8× larger
ALHC
$1.2B
$669.7M
NEU
Growing faster (revenue YoY)
NEU
NEU
+70.3% gap
NEU
-4.5%
-74.7%
ALHC
Higher net margin
NEU
NEU
16.7% more per $
NEU
17.6%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
-2.9%
NEU

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALHC
ALHC
NEU
NEU
Revenue
$1.2B
$669.7M
Net Profit
$11.4M
$118.1M
Gross Margin
33.0%
Operating Margin
21.4%
Net Margin
0.9%
17.6%
Revenue YoY
-74.7%
-4.5%
Net Profit YoY
-6.3%
EPS (diluted)
$12.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
NEU
NEU
Q1 26
$1.2B
$669.7M
Q4 25
$1.0B
$635.4M
Q3 25
$993.7M
$690.3M
Q2 25
$1.0B
$698.5M
Q1 25
$926.9M
$700.9M
Q4 24
$701.2M
$654.6M
Q3 24
$692.4M
$724.9M
Q2 24
$681.3M
$710.2M
Net Profit
ALHC
ALHC
NEU
NEU
Q1 26
$11.4M
$118.1M
Q4 25
$-11.0M
$81.3M
Q3 25
$3.7M
$100.3M
Q2 25
$15.7M
$111.2M
Q1 25
$-9.1M
$125.9M
Q4 24
$-31.1M
$110.7M
Q3 24
$-26.4M
$132.3M
Q2 24
$-24.0M
$111.6M
Gross Margin
ALHC
ALHC
NEU
NEU
Q1 26
33.0%
Q4 25
30.0%
Q3 25
30.4%
Q2 25
31.6%
Q1 25
33.7%
Q4 24
31.7%
Q3 24
33.6%
Q2 24
30.8%
Operating Margin
ALHC
ALHC
NEU
NEU
Q1 26
21.4%
Q4 25
-1.0%
17.3%
Q3 25
0.8%
18.9%
Q2 25
2.2%
20.5%
Q1 25
-0.6%
22.8%
Q4 24
-3.2%
20.3%
Q3 24
-2.8%
23.4%
Q2 24
-2.7%
20.7%
Net Margin
ALHC
ALHC
NEU
NEU
Q1 26
0.9%
17.6%
Q4 25
-1.1%
12.8%
Q3 25
0.4%
14.5%
Q2 25
1.5%
15.9%
Q1 25
-1.0%
18.0%
Q4 24
-4.4%
16.9%
Q3 24
-3.8%
18.3%
Q2 24
-3.5%
15.7%
EPS (diluted)
ALHC
ALHC
NEU
NEU
Q1 26
$12.62
Q4 25
$-0.04
$8.67
Q3 25
$0.02
$10.67
Q2 25
$0.07
$11.84
Q1 25
$-0.05
$13.26
Q4 24
$-0.15
$11.57
Q3 24
$-0.14
$13.79
Q2 24
$-0.13
$11.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
NEU
NEU
Cash + ST InvestmentsLiquidity on hand
$705.6M
$73.2M
Total DebtLower is stronger
$939.6M
Stockholders' EquityBook value
$206.9M
$1.7B
Total Assets
$1.3B
$3.5B
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
NEU
NEU
Q1 26
$705.6M
$73.2M
Q4 25
$604.2M
$77.6M
Q3 25
$644.1M
$102.5M
Q2 25
$503.8M
$70.3M
Q1 25
$479.5M
$118.3M
Q4 24
$470.6M
$77.5M
Q3 24
$381.0M
$80.3M
Q2 24
$363.7M
$87.6M
Total Debt
ALHC
ALHC
NEU
NEU
Q1 26
$939.6M
Q4 25
$323.2M
$883.4M
Q3 25
$322.7M
$783.1M
Q2 25
$322.3M
$841.8M
Q1 25
$321.9M
$990.6M
Q4 24
$321.4M
$971.3M
Q3 24
$212.0M
$1.1B
Q2 24
$211.7M
$1.2B
Stockholders' Equity
ALHC
ALHC
NEU
NEU
Q1 26
$206.9M
$1.7B
Q4 25
$179.3M
$1.8B
Q3 25
$161.9M
$1.7B
Q2 25
$141.0M
$1.6B
Q1 25
$108.1M
$1.5B
Q4 24
$99.9M
$1.5B
Q3 24
$114.5M
$1.4B
Q2 24
$123.7M
$1.2B
Total Assets
ALHC
ALHC
NEU
NEU
Q1 26
$1.3B
$3.5B
Q4 25
$1.1B
$3.5B
Q3 25
$1.1B
$3.2B
Q2 25
$1.0B
$3.2B
Q1 25
$895.6M
$3.2B
Q4 24
$782.1M
$3.1B
Q3 24
$692.3M
$3.2B
Q2 24
$716.3M
$3.2B
Debt / Equity
ALHC
ALHC
NEU
NEU
Q1 26
0.54×
Q4 25
1.80×
0.50×
Q3 25
1.99×
0.46×
Q2 25
2.29×
0.52×
Q1 25
2.98×
0.65×
Q4 24
3.22×
0.66×
Q3 24
1.85×
0.80×
Q2 24
1.71×
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
NEU
NEU
Operating Cash FlowLast quarter
$128.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
NEU
NEU
Q1 26
$128.7M
Q4 25
$-50.4M
$145.2M
Q3 25
$144.6M
$142.4M
Q2 25
$29.1M
$161.1M
Q1 25
$16.6M
$120.3M
Q4 24
$-8.7M
$185.2M
Q3 24
$26.2M
$116.6M
Q2 24
$23.5M
$115.0M
Free Cash Flow
ALHC
ALHC
NEU
NEU
Q1 26
Q4 25
$-55.4M
$117.2M
Q3 25
$139.1M
$122.1M
Q2 25
$21.1M
$144.8M
Q1 25
$8.4M
$107.3M
Q4 24
$-18.0M
$170.6M
Q3 24
$16.9M
$102.4M
Q2 24
$11.8M
$100.0M
FCF Margin
ALHC
ALHC
NEU
NEU
Q1 26
Q4 25
-5.5%
18.4%
Q3 25
14.0%
17.7%
Q2 25
2.1%
20.7%
Q1 25
0.9%
15.3%
Q4 24
-2.6%
26.1%
Q3 24
2.4%
14.1%
Q2 24
1.7%
14.1%
Capex Intensity
ALHC
ALHC
NEU
NEU
Q1 26
3.6%
Q4 25
0.5%
4.4%
Q3 25
0.6%
2.9%
Q2 25
0.8%
2.3%
Q1 25
0.9%
1.9%
Q4 24
1.3%
2.2%
Q3 24
1.3%
2.0%
Q2 24
1.7%
2.1%
Cash Conversion
ALHC
ALHC
NEU
NEU
Q1 26
11.27×
Q4 25
1.79×
Q3 25
38.77×
1.42×
Q2 25
1.86×
1.45×
Q1 25
0.96×
Q4 24
1.67×
Q3 24
0.88×
Q2 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons